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Microbeam radiation therapy (MRT) is a form of cancer
treatment in which a single large dose of radiation is spatially
fractionated in-line or grid-like patterns. Preclinical studies
have demonstrated that MRT is capable of eliciting high
levels of tumor response while sparing normal tissue that is
exposed to the same radiation field. Since a large fraction of
the MRT-treated tumor is in the dose valley region that is not
directly irradiated, tumor response may be driven by
radiation bystander effects, which in turn elicit a microvas-
cular response. Differential alterations in hemodynamics
between the tumor and normal tissue may explain the
therapeutic advantages of MRT. Direct observation of these
dynamic responses presents a challenge for conventional ex
vivo analysis. Furthermore, knowledge gleaned from in vitro
studies of radiation bystander response has not been widely
incorporated into in vivo models of tumor radiotherapy, and
the biological contribution of the bystander effect within the
tumor microenvironment is unknown. In this study, we
employed noninvasive, serial observations of the tumor
microenvironment to address the question of how tumor
vasculature and HIF-1 expression are affected by microbeam
radiotherapy. Tumors (approximately 4 mm in diameter)
grown in a dorsal window chamber were irradiated in a
single fraction using either a single, microplanar beam (300
micron wide swath) or a wide-field setup (whole-window
chamber) to a total dose of 50 Gy. The tumors were optically
observed daily for seven days postirradiation. Microvascular
changes in the tumor and surrounding normal tissue differed
greatly between the wide-field and microbeam treatments.
We present evidence that these changes may be due to
dissimilar spatial and temporal patterns of HIF-1 expression
induced through radiation bystander effects.  2015 by Radiation
Research Society
INTRODUCTION
Recent advances in radiation physics have brought the
field of microbeam radiotherapy (MRT) closer to clinical
application. This technology typically delivers spatially
fractionated doses of hundreds of gray (Gy) in repeated,
submillimeter microplanar patterns separated by wider
regions that receive very little (1–10%) dose. Because this
technique is in preclinical development, these doses and
geometries vary greatly between studies, and ideal treatment
schemes are currently being investigated (1–3).
MRT studies have reported specific tumor cell kill with
relatively minimal normal tissue effects. One hypothesis
that explains this normal tissue resistance involves a greater
capacity for morphologically and functionally normal
vasculature to recover from spatially fractionated treatment,
relative to the unregulated, immature vasculature associated
with tumors (4). However, this proposal has yet to be
validated. It is likely that the tissue response to microbeam
treatment is temporally complex, making it difficult to
discern the kinetics of the tissue response solely from ex
vivo pathologic analysis.
Although abnormal in structure, tumor-associated vessels
are the source of oxygen delivery, and it is well established
that the aberrant vasculature characteristics contributes to
tumor hypoxia (5). Structural and functional alterations due
to radiation damage may further contribute to changes in
tumor oxygenation (6, 7). Tumor hypoxia has been
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associated with poor outcomes in a number of clinical
studies (8, 9). Furthermore, improvements in oxygenation
during fractionated radiotherapy are associated with differ-
ential outcomes when compared to tumors that do not
reoxygenate (10–12). It is not known how hypoxia is altered
after microbeam radiotherapy. This study establishes these
effects for microbeam compared with whole-window
radiotherapy when both modalities deliver the same dose.
We have previously shown that the vascular response to
radiation exposure in tumors is mediated by upregulation of
HIF-1, a transcription factor responsible for regulating
hypoxia-related gene expression. HIF-1 regulates genes that
drive angiogenesis, tumor cell invasiveness, metastasis and
proliferation (13). HIF-1 is a heterodimer, consisting of
constitutively produced HIF-1a and HIF-1b. HIF-1a is
normally kept at low levels in the presence of oxygen via
proteosomal degradation mediated by the VHL complex.
However, exposure to radiation can cause stabilization of
HIF-1a expression through a number of mechanisms (6),
leading to upregulation of many downstream genes.
In this study we used the dorsal skinfold window chamber
model to serially compare the vascular effects of whole-
tumor versus microbeam radiotherapy. This animal model is
uniquely capable of offering high-resolution images of the
tumor and associated vasculature at optical wavelengths.
Furthermore, it facilitates serial noninvasive measurements
of the tumor microenvironment, allowing for the observa-
tion of temporally evolving aspects of tumor growth and
treatment response, including vascular disruption, perfu-
sion, angiogenesis and the regulation of HIF-1 expression
(via fluorescent protein reporters) (14). These advantages
are particularly important for a thorough understanding of
microphysiological radiation effects, since no other in vivo
model effectively facilitates the tracking of temporal
changes at the level of single microvessels.
Investigation of tumor vascular parameters through image
analysis is technically challenging. Manual methods of
extracting quantitative image data are generally inefficient
and are prone to introducing user bias. Therefore, we have
developed automated methods for quantifying vascular
functional and structural changes after irradiation (15).
Tumor response is tracked through serial measurements
over a week-long time course, and derived microenviron-
mental parameters are statistically evaluated. Here we show
that spatial application of dose by a single microbeam elicits
differing effects on the tumor microvasculature through
unique patterns of disruption. Furthermore, we demonstrate
that HIF-1 signaling in adjacent nonirradiated tumor regions
is associated with this response.
MATERIALS AND METHODS
4T1-RFP-GFP Cell Line
A genetically engineered 4T1 murine mammary carcinoma cell line
was used for this study (16). This line was stably transfected with a
plasmid vector encoding a green fluorescent protein (GFP) reporter
(17). Expression of GFP in the cell is driven by a HIF-1-modulated
hypoxia responsive element (HRE). An HRE is a DNA sequence in
the promoter region of a gene that HIF-1 binds with to induce
enhanced gene transcription. Thus HIF-1 expression within a tumor
grown from this line can be directly visualized and quantified through
the intensity of the GFP signal. This line was also stably transfected
with a red fluorescent protein (RFP) gene under control of the
cytomegalovirus (CMV) promoter. Expression of RFP is constitutive
(always active) and is used to visualize the spatial location and extent
of the tumor.
Dorsal Window Chamber Preparation
A thorough explanation of the dorsal window chamber surgical
procedure is provided in previously published articles (14, 18). Briefly,
nude mice were anesthetized using a ketamine/xylazine preparation and
the surgical area was disinfected using Exidinet and ethanol. In each
mouse, a circular incision, 12 mm in diameter, was made in the loose
skin of the dorsal surface. The skin and underlying connective tissue
were removed completely. The dorsal skin was pinched up to form a
skin fold, which exposed the dermal tissue on the opposite side of the
area of excised skin. The incision was aligned with a hole cut into a
specially constructed titanium frame, which was then sutured onto the
animal to form a stable window into the underlying tissue.
Approximately 2 3 104 4T1-GFP-RFP cells suspended in serum-free
media were injected beneath the exposed fascial plane. A sterile glass
coverslip was then inserted into the titanium frame to form an airtight,
optically-accessible window into the inoculated tumor and surrounding
tissue. Irradiation was carried out one week after tumor cell transplant,
when solid, vascularized tumors 3–5 mm in diameter had been formed.
We have shown previously that these tumors are hypoxic and express
HIF-1 at this size range (19–21).
Optical Data Acquisition and Image Processing
A detailed description of the data acquisition methods and image
processing algorithms are provided in the supplemental methods.
Briefly, hyperspectral image series were used to spectrally separate
oxy/deoxy hemoglobin components for analysis of hemoglobin O2
saturation (22). Total hemoglobin data (oxy þ deoxy hemoglobin)
were used to measure vascular hemoglobin concentrations. We also
used the hyperspectral system to separate fluorescent reporters of
interest (RFP and GFP) from tissue autofluorescence to more
accurately quantify levels of expression.
Total hemoglobin images were used to quantify vascular structural
features (i.e., vessel centerlines, diameters, branch points) using the
described vessel segmentation/skeletonization algorithm. Video im-
ages of blood flow within the tumor were used to map and quantify
flow speed and direction. The algorithm used for this procedure is
briefly described in the supplemental methods, and more thoroughly
presented in a previously published article (23).
Window Chamber Tumor Irradiation
A nanotechnology-based X-ray experimental irradiator specifically
designed to produce microbeam radiation was used for this study (24–
26). More detailed information about the dosimetry and geometry of
this microbeam radiation technique can be found in refs. (24–26). This
novel irradiation system utilizes a line source design (instead of the
conventional point source) that is optimized to produce the highest
beam intensity for the microbeam. Anesthetized mice were placed in
the system with their titanium frames immobilized on a heated stage.
Animals treated in the microbeam tumor irradiation group were
exposed to 50 Gy at a dose rate of 1 Gy/min as 160 kVp photons
passed through a collimator to produce a single full-width half-max
(FWHM) 300 lm wide microbeam through the middle of the tumor
(Fig. 1A). Radiation intensity fell off sharply, with areas greater than
200 lm from the beam centerline receiving less than 10% of the
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maximum dose. This beam spanned the width of the window along its
centerline, and its track was visualized using a radiation-sensitive film
glued to the front of the glass coverslip (Fig. 1B). For the whole tumor
irradiation group, the microbeam collimator was removed, and the
entire window was irradiated while sparing the rest of the animal’s
body. In both irradiation procedures, the delivered dose was 50 Gy
(25, 27). The dose of 50 Gy was selected based on preliminary
experiments whereby a single microbeam of radiation induced a tumor
vascular response and the corresponding wide-field exposure allowed
sufficient tissue viability for biologic comparisons. A mock-irradiated
group was also used as a control.
Window Chamber Imaging Schedules
The methods outlined above were used to optically observe and
quantify changes in HIF-1 and vascular response after irradiation.
Animals were imaged approximately 2 h prior to irradiation, 2 h
postirradiation and each day following through seven days postirra-
diation. For each time point, the windows were imaged using the
hyperspectral system described above, with illumination, filtering and
exposure parameters adjusted to capture total hemoglobin/saturation,
GFP fluorescence emission and RFP fluorescence emission. The
tumor and surrounding area were imaged at 2.53 magnification for
these optical components, and it was from these images that the
regions of tumor core, rim and tumor-associated normal tissue were
identified (Supplementary Fig. S1; http://dx.doi.org/10.1667/
RR13712.1.S1). Video images were also collected in a 24 Hz, 128
frame series at 53 magnification to capture the movement of discrete
red blood cells as they moved through the vasculature.
Statistical Analysis
After processing the acquired data for the extraction of microen-
vironmental parameters, median values were calculated within each
spatial region at each time point, for each animal. We then calculated
the linear fit of the change in median values for each region within
each animal. The slope of this line represented the rate of change of
any particular parameter over the treatment time course. Within each
region, slopes were grouped according to treatment type (i.e.,
microbeam, whole or mock irradiation, with N ¼ 6, 6 and 5,
respectively), and statistical analysis using one-way ANOVA was
used to detect significant treatment effects. The Tukey-Kramer method
was then applied to these results to detect pair-wise statistical
significance between treatment groups. We also calculated the time-
averaged GFP expression in the tumor rim as a percentage of overall
expression, and applied the same statistical tests for significant
differences between treatment groups. In all figures, error bars
represent the standard error of the mean.
Histological Analysis
After the completion of imaging on day 7, animals were euthanized
and their window chamber tumors were immediately extracted and
snap frozen. The frozen tumors were then processed by routine
methods and multiple (at least four) successive 4 lm sections were
hematoxylin and eosin (H&E) stained. After histological preparation,
cellular features were evaluated by a pathologist who was blinded to
the treatment groups at the time of assessment.
Animal Welfare Statement
All procedures described in this study were performed in
accordance with animal welfare protocols approved by Duke
University’s Institutional Animal Care and Use Committee.
RESULTS
Vascular Structure
Qualitative observation of tumors irradiated with the
single microbeam showed a consistent pattern of vascular
expansion after radiation. Angiogenic vessels were prefer-
entially directed into the postirradiation beam path (Fig. 2).
In comparison, neither the wide-field nor the mock-treated
tumors showed a similar effect; in these cases, angiogenesis
did occur, but it was generally less profound and showed no
particular directional preference.
Using one-way ANOVA/Tukey-Kramer analysis as
described above, we observed no significant differences in
the rate of change of intratumoral vascular length density or
percentage vascular area over time among any of the
treatment groups (Fig. 3A and C). However, within the
tumor-associated normal tissue, the wide-field group
displayed a significantly decreased vascular length density
by the end of the time course relative to the mock group (P
¼ 0.0147) and a near significant decrease relative to the
microbeam group (P¼0.054) (Fig. 3B). By day 7, the wide-
field group also showed a significantly greater decrease in
vascular area within the tumor-associated normal tissue,
compared to either the mock or microbeam groups (P ¼
0.0124 and P ¼ 0.0222) (Fig. 3D). These data indicate a
radiation-induced vascular regression within the tumor-
FIG. 1. Microbeam irradiation. Panel A: The radiation intensity profile had a full-width half-max of
approximately 300 lm. Panel B: Window chamber-grown tumors were irradiated with the source situated above
the window. The radiation penetrated the tumor orthogonally to the tissue plane. The length of the beam spanned
the 13 mm diameter window.
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FIG. 2. Patterns of angiogenesis after irradiation: Representative images of tumor-associated vasculature
overlaid with hemoglobin oxygen saturation values. Three different microbeam, two different mock, and two
different wide-field windows are shown. Longitudinal imaging at time points prior to irradiation through day 7
allowed visualization of the changes in tumor vascularization patterns. Over time, the patterns of vascular
expansion in the microbeam group indicated a preferential infiltration of the irradiated portion of the tumor
(arrows, with irradiated portion highlighted in red). Compared to the microbeam group, the angiogenic response
within the mock and wide-field groups showed no apparent localized patterns of expansion or changes in vessel
orientation. Vessels in these groups generally radiate inward from the tumor edge without notable variations in
vessel density.
FIG. 3. Changes in vascular length density and percentage vascular coverage over time. No significant
differences in the rate of change in either parameter were observed among the treatment groups within the tumor
itself (panels A and C). Within the tumor-associated normal tissue, however, the wide-field group showed a
significant drop in vascular length density relative to the mock group (panel B) (P¼ 0.0147). A significant drop
in the wide-field group’s percentage vascular coverage was observed on the final day relative to both mock and
microbeam groups (panel D) (P¼ 0.0124 and P¼ 0.0222, respectively)
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associated normal tissue region of the wide-field group. The
lack of effect within this region in the mock and microbeam
groups may be due to the fact that most of the tissue in these
regions received virtually no radiation dose (microbeam), or
no radiation at all in the mock controls.
Microvessel Perfusion and Flow Direction
We next analyzed hemodynamics from videos to
determine microvessel blood flow patterns using our
previously described mapping algorithm (15). Blood flow
was maintained within the vascular network after treatment.
We did observe patterns of vascular reorganization within
the microbeam group, however. Consistent with structural
data presented above, vessels tended to branch out into the
region of radiation exposure in the microbeam group. This
was particularly notable in one tumor, where vessels
initially running largely parallel to the beam path on the
day of irradiation changed their orientation to a more
perpendicular orientation in just a few days (Supplementary
Fig. S2; http://dx.doi.org/10.1667/RR13712.1.S1).
Spatial and Temporal Patterns of HIF-1 Expression
Median HIF-1-GFP signal consistently increased at each
successive time point in the mock and single-microbeam
groups (Fig. 4A). This constant increase was also observed
in the wide-field group through day 5, however at day 6 and
7 the signal decreased from the preceding day. To determine
whether this effect was due to cell death we also measured
changes in RFP expression (Fig. 4B). Since RFP serves as a
constitutive reporter, the expression of this protein should
serve as a concurrent indicator of the number of viable cells
in the tumor. We therefore defined the ratio of GFP:RFP
expression, as GFP expression per viable tumor cell.
Tumor-wide GFP:RFP expression showed no statistically
significant trends (Fig. 4C). However, the GFP:RFP
expression in the tumor rim (integrated over all time points)
was significantly higher in the microbeam group than in
either the mock or wide-field groups (P ¼ 0.0323 and P ¼
0.0425, respectively) (Fig. 4D).
Alterations in Vascular Hemoglobin Concentration
The overall change in vascular hemoglobin concentration
within the tumor was highest in the microbeam group (Fig.
5A). The most notable rate of change began on the third day
postirradiation. The effect was not noted in the tumor-
associated normal tissue (Fig. 5B), but was prominent in the
tumor itself, both within the rim (Fig. 5C) and core (Fig.
5D).
The rate of change in hemoglobin concentration within
the tumor was significantly different for the wide-field
group compared to the microbeam group (P¼ 0.0243) (Fig.
6A). When the time course was split into two segments
FIG. 4. Changes in fluorescent reporter expression over time. Both the microbeam and mock group showed a
consistent increase in GFP (indicating HIF-1) over time, whereas the wide-field group saw a decay in expression
around day 5 (panel A). A similar decay was observed in the expression of RFP (constitutively expressed) (panel
B). When RFP was used to control for total protein expression, the ratio of median GFP to median RFP showed
that the microbeam group was the only one to show a notable increase in relative expression of GFP (panel C).
Within the tumor rim, GFP expression was proportionally higher in the microbeam group than in the mock or
wide-field groups (panel D). (P¼ 0.0323 and P¼ 0.0425, respectively)
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(pretreatment – day 3 and day 3–7), the rate of change in
hemoglobin concentration was not significantly different
among any groups within the first timeframe (Fig. 6B).
Within the second timeframe, however, the rate of change
within the microbeam group was significantly higher than
either the mock or wide-field groups (P ¼ 0.0285 and P ¼
0.0270, respectively) (Fig. 6C). Only the microbeam group
showed a significant difference in rates between the two
timeframes (P ¼ 0.0215) (Fig. 6D).
Alterations in Hemoglobin Oxygen Saturation (Wide-Field
Group)
Hemoglobin saturation was tracked in the three different
treatment groups (Fig. 7A). Concurrent with the drop in
HIF-1 reporter expression after wide-field irradiation, we
observed an increase in hemoglobin oxygen saturation
relative to the mock and microbeam groups persisting
through day 6 and 7 (P ¼ 0.0039 and P ¼ 0.0035,
respectively) (Fig. 7B).
Histological Analysis of Tumors
Representative images of the tumors are shown in
Supplementary Fig. S3 (http://dx.doi.org/10.1667/
RR13712.1.S1). Histologic findings varied between the
three treatment groups. In the mock group, the neoplastic
nodules were composed of haphazardly arranged pleomor-
phic polygonal to spindle-shaped cells with moderate
anisocytosis and anisokaryosis. The number of mitotic
figures in the mock group ranged from 30 to 55 per 10 high
power fields (403). Also observed were randomly scattered,
patchy areas of lytic necrosis (affecting anywhere from less
than 5% of the mass to up to 20% of the mass in different
animals and in different planes of section).
Relative to the mock group, the neoplastic cells of the
wide-field group were extremely pleomorphic and very
large. Individual cells were up to 50 lm in diameter. There
were frequent multinucleated cells with up to 8 nuclei in a
single cell. Severe anisocytosis and anisokaryosis were
noted, with some nuclei up to 8 times larger than others.
The mitotic index ranged from 12–25 mitotic figures per 10
high-power fields (403), and over half of the mitotic figures
were bizarre. Patchy foci of lytic necrosis ranged from less
than 5% up to 25% of the mass.
Within the microbeam-irradiated tumors, two distinct
phenotypes were observed. In most of the tissue sections
approximately 80% of the neoplastic mass resembled the
mock group of tumors. However, the remaining 20% of the
tissue was composed of a central or slightly off-center,
roughly linear band of neoplastic tissue that resembled the
wide-field group of irradiated masses with larger, more
pleomorphic cells. This band of tissue ranged from about
0.2–0.5 mm in diameter. Foci of lytic necrosis in both of the
neoplastic populations ranged from less than 5% up to 20%
of the mass.
In summary, mock-treated tumors showed a cellular
phenotype typical for this particular cell line. Patchy areas
of necrosis were observed, presumably in the areas of severe
hypoxia. The number of mitotic cells present in the tumor
indicated viability and continued patterns of growth. In
FIG. 5. Changes in vascular hemoglobin concentration over time. Microbeam irradiation elicited a biphasic
effect on vascular hemoglobin concentration within the tumor (panel A). Over the first four days of the time
course, hemoglobin concentration remained relatively constant, compared to the marked increase later seen over
the last four days. In comparison, the feeding vessels of the tumor-associated normal tissue maintained a more
constant rate of change that did not seem to be affected by microbeam treatment (panel B). These vessels may
have helped initiate the vascular response seen the tumor rim, and to a larger extent, the tumor core (panels C and
D).
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FIG. 6. Rates of change in vascular hemoglobin concentration within tumors. Both mock- and microbeam-
treated tumors showed a consistent increase in vascular hemoglobin concentration over the entire time course. In
contrast, concentrations within wide-field-treated tumors tended to remain static (panel A). Between the day of
treatment and the third day post, no significant differences in the rate of change were observed among the
treatment groups (panel B). From day 3–7, however, the microbeam group had a rate of change significantly
greater than either the mock or wide-field groups (panel C) (P¼ 0.0285 and P¼0.0270, respectively). When the
rates of change were compared over the two timeframes, only the microbeam-treated tumors showed a
significant change (panel D) (P¼ 0.0215).
FIG. 7. Changes in hemoglobin O2 saturation within the tumor-associated vasculature. Within the wide-field
group, hemoglobin oxygen saturation increased abruptly over the last few days of the time course (panel A). The
average rate of change was significant within the wide-field group when compared to either mock or microbeam
treatments (panel B) (P ¼ 0.0039 and P ¼ 0.0035, respectively).
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contrast, tumor cells in the whole-field group showed
indications of radiation-induced damage; giant multinucle-
ated cells and aberrant mitosis were commonly observed.
The microbeam-treated tumors showed a linear band
through the tumor with the same phenotype as the wide-
field group. The width of this zone was consistent with the
width and orientation of the microbeam. Cells outside of the
irradiated region were identical to the mock-treated tumors.
DISCUSSION
The data presented here compare the effects of 50 Gy
irradiation, using either wide-field or microbeam techniques
(with mock-treated controls), on tumors grown in the skin-
fold window chamber. To evaluate the effects of the various
treatments on the tumor microenvironment, we employed the
methods described above on images collected daily over the
pre- and post-treatment time course. Data on vessel structure
and function indicated the extent that radiation exposure
caused vascular disruption within the tumor, as well as
determine its capacity for recovery in the days afterwards.
Measurements of hemoglobin concentration and hemoglobin
saturation provided complementary information on the
perfusion and oxygen transport capabilities of the affected
vasculature. Furthermore, regulation of HIF-1 expression was
tracked and quantified through the observation of GFP
expression. H&E histology was performed after tumors were
extracted on the final day of imaging, and these results
confirmed that the differing irradiation techniques produced
distinctive patterns of cell death within the tumor: diffuse
cellular damage and death in the wide-field-irradiated tumors,
and linearized, focal cell damage and death in the
microbeam-irradiated tumors. These comprehensive data
provide multi-parametric assessment of physiologic pertur-
bation and recovery in the tumors that were mock treated,
microbeam and wide-field irradiated. Through automated
demarcation of the predefined tumor regions, the spatial
dynamics of these effects were also elucidated.
Over the eight day time course, we found that exposure to
50 Gy causes: 1. unique physiologic changes in different
tumor/normal tissue regions and 2. differential effects
between wide-field and microbeam irradiations. We pro-
pose that microbeam irradiation causes an upregulation in
HIF-1 in the nonirradiated portions of the tumor through
bystander mechanisms. HIF-1, in turn, potentiates vascular
recovery. In contrast, wide-field-treated tumor irradiation
results in widespread cell death. Cell death contributes to
reoxygenation because a lowered cell density will reduce
oxygen consumption. A visual representation of this
proposed model is featured in Supplementary Fig. S4
(http://dx.doi.org/10.1667/RR13712.1.S1).
Wide-Field Irradiation
A decrease in vascular length density and percentage
vascular coverage was observed after treatment in the
tumor-associated normal tissue. In contrast, vascular density
and percentage vascular coverage were unchanged in the
tumor. The lack of change in hemoglobin concentration was
in contrast with the other treatment groups, where
concentrations increased over time. These results were
interpreted as an inhibition of vascular growth due to the
radiation treatment. The vessels that remained after
treatment showed no apparent lack of functionality,
however, as perfusion persisted there was no visible
vascular stasis.
Hemoglobin oxygen saturation increased dramatically in
the last days of the study. This effect suggested oxygen
consumption had decreased. The pathologic data showed
that there was widespread cell death, which would reduce
oxygen consumption rate. These results are consistent with
the prevailing theory that oxygenated cells are preferentially
killed by radiation, freeing up oxygen for diffusion into
formerly hypoxic tumor regions (6). Previously, we had
shown that HIF-1 induction occurs coincidentally with
reoxygenation after three daily fractions of 5 Gy in this
tumor model (16). We observed a dissimilar trend here,
however. As tumor oxygenation increased, HIF-1 de-
creased. The lack of HIF-1 induction was likely due to
the very high radiation dose the tumor received. A
substantially reduced number of viable cells would reduce
HIF-1-driven GFP production. The concurrent drop in RFP
expression supports this explanation, as well as the
observation of widespread tumor cell death in histological
samples.
Single-Microbeam Irradiation
Radiation was delivered by a 300 lm wide beam that cut
through the tumor, leaving nonirradiated tumor volumes on
either side. The geometry of this scheme resulted in
relatively smaller fractions of the tumor rim and tumor-
associated normal tissue receiving radiation. Histological
analysis of the microbeam-treated tumors confirmed this
pattern of radiation exposure, with a central linear region
displaying radiation damage similar to the wide-field group,
and an outer, nonirradiated mass with histological features
similar to the mock-treated tumors.
No direct evidence of vessel depletion or loss of
functionality was observed in the microbeam-irradiated
group. In fact, changes in vascular length density and
percentage vascular coverage after microbeam irradiation
largely followed the same trend as mock-irradiated controls.
A visual assessment of the pattern of vascular response
reveals a pronounced angiogenic effect originating within
the tumor-associated normal tissue along the radiation path.
Vascular function remained unaltered in the microbeam
group, as assessed through maps of blood flow speed.
Furthermore, we observed no significant alteration in
hemoglobin oxygen saturation after treatment, suggesting
that tumor oxygenation remained stable throughout the time
course. Unique patterns of vascular remodeling were
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highlighted in the flow direction maps, however. Here we
observed that blood flow was redirected into the irradiated
beam area. Thus, both functional and structural analyses of
the vasculature indicate that microbeam irradiation leads to
an increase in angiogenesis, enhancing the blood supply to
irradiated tissue.
This vascular adaptation to localized radiation may be
facilitated through HIF-1 expression, since it has been
shown that HIF-1 expression is increased after radiation
treatment (21). Spatial analysis showed that the primary area
of HIF-1 expression was not within the irradiated tumor
core. A relatively high amount of HIF-1 activity was found
in the tumor rim and this increase was circumferential,
rather than following the path of the microbeam treatment.
These data provide indirect evidence that bystander
signaling increases HIF-1 expression, which perhaps
emanates from the irradiated area, into nonirradiated tumor
tissues. The radiation bystander process is thought to be at
least partially mediated through the radiation-induced
production of free radicals (28, 29). Damage to mitochon-
dria may further potentiate this oxidative stress (30). The
production of the diffusible and long-lived reactive species,
hydrogen peroxide and nitric oxide, have been prominently
implicated in the bystander response (31). Bystander-
affected cells have been shown to increase the production
of both of these reactive species. Both hydrogen peroxide
and nitric oxide, in turn, stabilize HIF-1 in the presence of
oxygen (16, 32). Additionally, it has been shown that
reactive oxygen species-mediated HIF-1 induction occurs
on the transcriptional level and is dependent on NF-jB (33).
Thus, the observation of increased HIF-1 expression in the
rim, despite a lack of any direct damage from radiation,
suggests that bystander signaling is active here. The
increase in HIF-1 expression after microbeam treatment
likely contributes to the angiogenic response because it
upregulates expression of two proangiogenic cytokines,
VEGF and angiopoeitin-2 (13).
The sharp increase in hemoglobin concentration begin-
ning on the third day post treatment further implicates
bystander-induced HIF-1 upregulation in the post-micro-
beam irradiation response. A primary effect of VEGF
upregulation is an increase in vascular permeability. As a
result of this change, plasma leakage into the interstitial
space will cause microvascular hematocrit to rise. This is
consistent with the postirradiation increase in hemoglobin
concentration within the tumor.
Interpretation of Treatment Effects
The laboratories of Fuks and Kolesnick have theorized a
model in which endothelial cell apoptosis serves as the
primary mechanism dictating tumor radiation sensitivity
after high doses per fraction (34). This alternative
hypothesis challenges the classical model of tumor
clonogenic cell death as the driving mechanism of radiation
response (35). The relative role that vascular destruction
plays in dictating tumor radiation response is controversial,
however (34–39).
The data presented here do not support the hypothesis that
vascular disruption occurs after high doses of radiation.
Within the microbeam group the structural and functional
characteristics of the vasculature as a whole did not change,
relative to the pre-treatment data. Post-treatment initiation of
a HIF-1 response in the tumor rim may have protected the
tumor against vascular depletion through the angiogenic
recruitment of blood vessels from the tumor-associated
normal tissue. These results, however, compare the tumor
microenvironmental effects of a single microbeam of
radiation to nonirradiated (mock-treated) or wide-field
irradiated tumors, which is not how this treatment will be
deployed if given with therapeutic intent. The most
common configuration used thus far has been multiple
parallel microbeam paths that traverse tumor and normal
tissue. In future studies, it will be important to examine how
traditional parallel microbeam patterns used in MRT affect
normal and tumor vascular function.
While angiogenesis is known to be a major factor in
tumor-mediated vascular expansion, an alternative hypoth-
esis presents vasculogenesis as the major factor after
radiation therapy. In this model, high-dose irradiation of
the tissue bed eradicates the vasculature within the treatment
field. Vascular function is reestablished through the de novo
(i.e., vasculogenic) formation of blood vessels. It has been
shown that vasculogenesis is achieved through the infiltra-
tion of endothelial progenitor cells from the peripheral
blood, assisted by bone marrow-derived myelomonocytes
expressing MMP-9 (an extracellular matrix degrading
enzyme) (40). This study was not designed to examine this
mechanism, but the results do not preclude that both
angiogenesis and vasculogenesis may play a combined role
in vascular response after partial tumor irradiation.
The driving factor in microvessel survival and/or recovery
after irradiation and the magnitude of this effect may be
dependent upon the particular radiation-treatment scheme
employed. Our results clearly indicate that vascular
expansion is potentiated when the tumor is partially spared.
We propose that this phenomenon is linked to both the
vascular protective and angiogenic effect of HIF-1, and the
unique pattern of expression observed in this scenario. HIF-
1 was shown to be upregulated primarily in the tumor rim,
which received relatively less radiation exposure than the
tumor core. Thus, the data presented here provide evidence
that tumor-mediated intercellular signals initiated in the
lethally irradiated portion of the tumor core enable vascular
recovery through the induced expression of HIF-1 in
nonirradiated portions of the tumor. Following this indirect
upregulation of HIF-1, a profound angiogenic and/or
vasculogenic response is observed. To confirm this
mechanistic link, quantification of native HIF-1 protein
stabilization and induction of HIF-1 target proteins is
warranted, as well as experimental elimination of reactive
species and/or disruption of HIF-1 to demonstrate causality.
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Owing to the known detrimental effects of HIF-1 with
respect to tumor radioresistance (13, 16, 32), these
observations provide evidence of possible detrimental
effects after the inhomogeneous tumor irradiation inherent
to spatially fractionated treatment, and thus strongly
indicates the need for more research on the mechanisms
behind the efficacy of MRT before moving forward to
clinical trials. In addition, this vascular contribution to
tumor radiation response may also play a major role in
conventional therapies, such as IMRT, where a marginal
miss (effectively a local spatially fractionated dose
distribution) may produce similar effects. The importance
of unintentional sparing of tumor margins is poorly
understood, and may be largely determined by the vascular
response, as seen here.
It is important to note, however, that the spatial
modulation of dose in this study is simplistic compared to
those typically employed in most spatial fractionation
techniques, including MRT. Characteristically, MRT uses
highly collimated, quasi-parallel arrays of X-ray micro-
beams of 50–600 keV in which a large array of thinner (25–
75 microns wide), higher dose (in the order of 100 Gy)
microbeams are employed and separated by wider (100–400
microns center to center) microplanar spaces (41) or larger
scale minibeams (500–700 microns wide) (42); our study
examines the tumor microenvironmental effects of a single
microbeam of radiation. Specifically, we utilized a 300 lm
wide microbeam through the tumor to administer 50 Gy
with 160 kVp photons at a dose rate of 1 Gy/min. The
‘‘valley dose’’ in our arrangement with the single
microbeam could be considered 300–400 lm from the
beam centerline where the tissue would receive less than 1%
of the maximum dose (Fig. 1A). Additionally, the radiation
exposure for these experiments was administered at a lower
dose rate (1 Gy/min) compared to synchrotron-based MRT
systems (500–800 Gy/s) (43). Intercellular signaling factors
in the more intricate geometries of spatial fractionation
techniques may produce variable effects dependent upon
geometry/dose-sensitive diffusion gradients (43–46). Nota-
bly, these preclinical MRT techniques have been associated
with normal tissue sparing and tolerance, tumor targeting
and maintenance of the normal microvasculature. Thus,
evidence presented here may not necessarily be applicable
to spatial fractionation techniques in general. However,
these data are cause for concern regarding the long-term
implications of unknown (as in the case of marginal misses)
or poorly investigated spatial heterogeneities in radiation
dose.
SUPPLEMENTARY INFORMATION
Fig. S1. Regional demarcation of tumor boundaries and
vessel segmentation. Panel A: Fluorescence reporter images
were used to identify the tumor boundary (red line). Panel
B: From this, regions of tumor-associated normal tissue,
tumor rim and tumor core were defined according to their
distance from the tumor boundary. Within each of these
regions, fluorescence signal was quantified. Additionally,
vessels were segmented, and Spatially localized vascular
parameters were calculated.
Fig. S2. Microbeam radiation effects on vascular function
over time. In this single-representative-window chamber,
the middle, left and right columns show bright field images,
mapped blood flow direction and mapped blood flow speed,
respectively. A notable change in vascular orientation was
observed. Here vessels initially oriented parallel to the beam
length were replaced by vessels running perpendicular to
the irradiation portion of the tumor. Blood flow analysis
showed no apparent loss of vascular function within the
window after microbeam irradiation, as indicated by the
detection of normal microvessel blood velocities.
Fig. S3. Histological analysis of extracted tumors. After
tumor extraction on day 7, the tumors were preserved and
histologically assessed using H&E staining (panels A, B
and C photomicrographs at 53 magnification, 400 lm scale
bar; panel D photomicrograph at 203 magnification, 100
lm scale bar). Panel A: In the mock group, central, patchy
necrosis was observed within the tumor core (arrows). Panel
B: The wide-field group showed more widespread damage,
with a large number of pleomorphic irregular cells, bizarre
mitotic figures and multinucleated cells. Panel C: The
microbeam treated tumors showed two distinct neoplastic
phenotypes. Radiation-damaged cells were primarily ob-
served within the linear regions corresponding to the
microbeam-treated volume (dashed lines). Panel D: Magni-
fied images of the irradiated region showed an abundance of
markedly enlarged, pleomorphic cells with bizarre mitotic
figures and multinucleation (arrows).
Fig. S4. A proposed model of tumor response to
microbeam versus wide-field irradiation. Microbeam irra-
diation causes an upregulation in HIF-1 in the nonirradiated
portions of the tumor through bystander mechanisms. HIF-
1, in turn, potentiates vascular recovery. In contrast, wide-
field tumor irradiation results in widespread cell death,
which eventually leads to reoxygenation due to decreased
oxygen consumptions.
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